Collectively, our data indicate that the administration of DSF or TTM increased or decreased the numbers of SLC31A1+-CD68+ and FDX1+-CD68+ pulmonary macrophages in the process of MA-ALI/ARDS, respectively. The gene discussed is CD68; the disease is acute respiratory distress syndrome.